Guido Parvis

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani et al. · Journal of Clinical Oncology · 2018 · 193 citations

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

Corrado Tarella, Roberto Passera, Michele Magni et al. · Journal of Clinical Oncology · 2010 · 166 citations · Full text

Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients

Umberto Vitolo, Gianluca Gaïdano, Barbara Botto et al. · Annals of Oncology · 1998 · 93 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Immunology +5

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome <i>TP53</i> mutated/deleted clones

Giovanna Carrà, Cristina Panuzzo, Davide Torti et al. · Oncotarget · 2017 · 75 citations · Full text

Pten Nuclear Pool, Chronic Lymphocytic Leukemia, Cell Regulation +12

Rituximab Maintenance Compared With Observation After Brief First-Line R-FND Chemoimmunotherapy With Rituximab Consolidation in Patients Age Older Than 60 Years With Advanced Follicular Lymphoma: A Phase III Randomized Study by the Fondazione Italiana Linfomi

Umberto Vitolo, Marco Ladetto, Carola Boccomini et al. · Journal of Clinical Oncology · 2013 · 62 citations · Full text